Answers are grounded in this paper and cite their sources.
Objective: nowadays resistant bacteria represent worldwide a public health problem leading in some cases to a stalemate without any possible treatment. Therefore early detection and identification of carbapenemase producing gram-negative bacteria (GNB) is of crucial importance. Consequently we conducted a study in a tertiary care hospital to analyze the resistance phenotype of the carbapenem resistant GNB (CRGNB). Methods: we collected all the CRGNB from September 2014 till January 2016, we took randomly 40/126 strains and performed a sensitivity test in addition to a real time multiplex PCR to detect the exact carbapenemase coding genes (bla SPC , bla IMP1, bla VIM , bla NDM , bla KPC , et bla OXA-48). The studied strains were: Escherichia coli (70%), Klebsiella pneumonia (20%), Enterobacter aerogenes (2,5%), Enterobacter cloacae (2.5%) et Klebsiella oxytoca (2.5%). Results: 100% of the studied strains were intermediate or resistant to ertapenem, 85% intermediate or resistant to imipenem and/or meropenem. 33 / 40 strains (82.5%) are bla OXA-48 positive et one strain (2.5%) is bla NDM positive. the OXA-48 were urinary strains of E coli. 6 / 40 strains (15%) did not express carbapenemase genes in molecular studies. Conclusion: we note a marked emergence of CPGNB especially bla OXA-48 with high resistance pattern leading to narrow therapeutic options. This requires a rapid detection of such strains of GNB so that to initiate quickly the right preventive and therapeutic measures to avoid hospital epidemics with disastrous consequences.
No takes yet. Share an insight, caveat, or question.
Malek et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: